ABSTRACT
We have presented a case of osseous echinococcosis and have reviewed the pathogenesis, pathology, diagnosis, and current treatment methods.
Subject(s)
Echinococcosis , Ilium , Adult , Agriculture , Bone Diseases/diagnosis , Bone Diseases/parasitology , Echinococcosis/diagnosis , Echinococcosis/parasitology , Humans , Italy/ethnology , Male , United StatesABSTRACT
The usefulness of tumor marker assay in pleural effusions for differential diagnosis is still debated. From the observation of common antigens on tissue polypeptide antigen (TPA) and keratins 8, 18 and 19 and vimentin, all substances contained in normal and neoplastic mesothelium, we felt it opportune to evaluate the use of TPA assay in 105 pleural effusions (46 benign and 59 malignant). The values were much higher than those found in blood. In hydrothorax the median value was 454 U/l (range, 59-1923), in exudative effusions 846 U/l (range, 258-4485), in metastatic pleural effusions 1277 U/l (range, 58-32352) and in mesotheliomas 7705 (range, 759-16000). The maximum value found in nonmalignant effusions was 4485 U/l; this value was taken as a cutoff level, so only 29.9% of the tumors were positive to the test. Our results showed this assay to be not very important for a differential diagnosis of malignant and nonmalignant pleural effusions. Nevertheless, the different TPA patterns in mesotheliomas (66.6% positive) and metastatic pleural effusions (15.9%) suggest that further studies are warranted.
Subject(s)
Antigens, Neoplasm/analysis , Keratins/analysis , Mesothelioma/diagnosis , Neoplasm Proteins/analysis , Peptides/analysis , Pleural Diseases/diagnosis , Pleural Effusion/immunology , Pleural Neoplasms/diagnosis , Vimentin/analysis , Adult , Aged , Aged, 80 and over , Diagnosis, Differential , Female , Humans , Keratins/immunology , Male , Mesothelioma/immunology , Middle Aged , Neoplasm Proteins/immunology , Pleural Neoplasms/immunology , Pleural Neoplasms/secondary , Tissue Polypeptide Antigen , Vimentin/immunologyABSTRACT
A combined determination of pleural fluid and tissue carcinoembryonic antigen (PF-CEA and T-CEA) by radioimmunoassay and immunoperoxidase staining technique respectively was performed in patients with malignant mesotheliomas (12), metastatic pleural carcinomas (17) and benign pleural diseases (seven). All PF-CEA-positive (greater than 39 ng/ml) cases were T-CEA-positive metastatic carcinomas. In contrast, 4/30 PF-CEA-negative (less than 39 ng/ml) cases were T-CEA-positive metastatic carcinomas (three cases) and idiopathic pleuritis (one case). These results suggest that CEA, though present in the tumour, is not always released in measurable amounts in effusions. Hence T-CEA content should be determined in the PF-CEA-negative cases when an early and definite diagnosis of tumour type is required to enable correct management of these patients. These ancillary tests aim at enhancing the level of confidence of the routine morphological diagnosis of serous surface malignancies in living patients using minimal intervention instead of resorting to open chest surgery.